Aetiology

Acanthosis nigricans (AN) is associated with numerous underlying diseases, both acquired and inherited, but most commonly with obesity and hyperinsulinaemia.[2][5][6]​​​ It is thought that these conditions may lead to the release of various growth factors that then cause epidermal hyperplasia.[2][20]​​​​[21][22]​​​ In some cases, there is no identifiable family history or associated medical condition and the cause is unknown.

Pathophysiology

While the detailed molecular pathogenesis of AN remains to be discovered, various endocrine and tumour-produced growth factors are postulated to play a role in AN development due to their effects on receptors present on epidermal cells.[2][20]​​[21][22]​ In particular, epidermal growth factor and transforming growth factor alpha may be produced by tumours associated with AN.[2][21]​ In obesity and diabetes-related AN, increased levels of various endocrine products, including insulin-like growth factor-1 (IGF-1) and insulin itself, may play a role as their receptors are present on epidermal keratinocytes.[2]​​[21][22]

Classification

Classification according to type[2]​​​

  • Benign AN

    • Unilateral or generalised lesions present at birth or early childhood

    • Familial with autosomal-dominant trait with variable penetrance

    • Some affected families have an autosomal-dominant mutation in fibroblast growth factor receptor 3 gene (FGFR3)

    • May be classified as a variant of epidermal naevus

    • Usually not associated with obesity or endocrine abnormalities

    • May be mosaic condition with an increased risk of developing generalised AN in the right setting, such as obesity or hyperinsulinaemia

  • Obesity-associated AN

    • Weight-dependent and correlates with increasing body mass index

    • Resolves with weight loss

    • Associated with insulin resistance, which often accompanies obesity

    • Clinical marker for identifying patients at risk for developing diabetes mellitus

  • Syndromic AN

    • Associated with genetic syndromes, particularly those in which insulin resistance, obesity, or fibroblastic growth factor defects are present

  • Malignant AN

    • Characterised by sudden onset and rapid spread

    • Described in all age groups, although most common onset in adulthood

    • Most common locations are flexures and posterior neck, although there is involvement of oral and genital mucosa in 35% of patients. Acral surfaces and skin overlying cutaneous metastases may also be involved

    • May co-exist with sign of Leser-Trelat, 'tripe palms', florid cutaneous papillomatosis, and generalised pruritus

    • Most commonly associated with intra-abdominal carcinomas, typically gastric adenocarcinoma. Carcinomas of the liver, uterus, breast, lung, pancreas and bowel are detected less frequently[10]

    • Activated by the tumour, and parallels the course of the cancer, often regressing with treatment and returning with tumour recurrence

  • Acral AN

    • Also known as acral acanthotic anomaly

    • Hyperpigmented, acanthotic plaques on extensor surfaces, such as elbows, knees, dorsal hands and feet

    • Usually seen in healthy individuals with darkly pigmented skin

  • Unilateral AN

    • May be the unilateral form of benign acanthosis nigricans

    • Not associated with endocrinopathy, obesity, or malignancy

  • Drug-induced AN

    • Rarely induced by systemic corticosteroids, nicotinic acids, oestrogens, oral contraceptives, insulin, methyltestosterone, topical fusidic acid, and pituitary extract

  • Mixed-type AN

    • Two of the above types of AN appearing in the same patient

    • Usually malignant AN in concurrence with another type

Use of this content is subject to our disclaimer